Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Comment in:
A fatal case of
serotonin syndrome after combined moclobemide-citalopram
intoxication.
Dams R, Benijts TH, Lambert WE, Van
Bocxlaer JF, Van Varenbergh D, Van Peteghem C, De Leenheer
AP.
Laboratorium voor Toxicologie, Universiteit Gent,
Belgium.
We present a case involving a fatality due to the
combined ingestion of two different types of antidepressants. A
41-year-old Caucasian male, with a history of depression and suicide
attempts, was found deceased at home. Multiple containers of medication,
the MAO-inhibitor moclobemide (Aurorix), the SSRI citalopram (Cipramil),
and the benzodiazepine lormetazepam (Noctamid) as active substance, as
well as a bottle of whiskey were present at the scene. The autopsy
findings were unremarkable, but systematic toxicological analysis (EMIT,
radioimmunoassay, high-performance liquid chromatography-diode-array
detection [HPLC-DAD], gas chromatography-nitrogen-phosphorus detection,
and gas chromatography-mass spectrometry) revealed the following:
ethanol (0.23 g/L blood, 0.67 g/L urine), lormetazepam (1.65 microg/mL
urine), cotinine (0.63 microg/mL blood, 5.08 microg/mL urine), caffeine
(1.20 microg/mL urine), moclobemide (and metabolites), and citalopram
(and metabolite). There upon, we developed a new liquid chromatographic
separation with optimized DAD, preceded by an automated solid-phase
extraction, for the quantitation of the previously mentioned
antidepressive drugs. The results obtained for blood and urine,
respectively, were as follows: Ro 12-5637 (moclobemide N'-oxide) not
detected and 424 microg/mL; Ro 12-8095 (3-keto-moclobemide) 2.26
microg/mL and 49.7 microg/mL; moclobemide 5.62 microg/mL and 204
microg/mL; desmethylcitalopram 0.42 microg/mL and 1.22 microg/mL; and
citalopram 4.47 microg/mL and 19.7 microg/mL. The cause of death was
attributed to the synergistic toxicity of moclobemide and citalopram,
both antidepressants, which, by intentional or accidental combined
ingestion, can produce a potentially lethal hyperserotoninergic state.
Based on the history of the case and pharmacology of the drugs involved,
the forensic pathologists ruled that the cause of death was multiple
drug intoxication, resulting in a fatal "serotonin syndrome," and that
the manner of death was suicide.
Publication Types:
PMID: 11300508 [PubMed - indexed for
MEDLINE]
|